by | Aug 11, 2023 | Uncategorized
Source: CureToday articles Post Content Read More
by | Aug 10, 2023 | Uncategorized
The FDA granted accelerated approval to talquetamab-tgvs for treatment of certain patients with relapsed or refractory multiple myeloma.The indication authorizes use of the agent for adults who received at least four prior lines of therapy, including a proteasome...
by | Aug 10, 2023 | Uncategorized
Source: CureToday articles The FDA granted an accelerated approval for Talvey to treat patients with relapsed/refractory multiple myeloma. Read More
by | Jul 7, 2023 | Uncategorized
The FDA announced several regulatory actions the past few weeks.Here is an overview of decisions that may be relevant to your practice.1. The FDA issued a ”safe to proceed” for an investigational new drug application for NY-ESO-1 TCR/IL-15 NK (Syena) — an engineered...
by | Jun 28, 2023 | Uncategorized
Source: Cure Today articles Supervised exercise can help to improve the immune system for patients with myeloma, recent research showed. Read More
by | Jun 22, 2023 | Uncategorized
Source: Cure Today articles It is essential for patients to live a healthy lifestyle while undergoing treatment for multiple myeloma, an expert said. Read More
